Astel­las' Friedre­ich’s atax­ia gene ther­a­py cleared for clin­i­cal study af­ter ear­li­er ver­sion stum­bled

Af­ter hit­ting a speed bump in its first at­tempt at de­vel­op­ing a gene ther­a­py for Friedre­ich’s atax­ia, Astel­las is ready to put a new ver­sion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.